The Trump administration recently debuted a new look for the official COVID-19 page on the White House website. The headline, ...

Sep. 20, 2024 — A new study highlights the role of natural killer T cells in influencing the immune response to dengue virus, potentially reducing the severity of ... Study Identifies Areas of ...

Promega technology used in the development of vaccines for infectious viral diseases will support a collaboration between Charles River and the Coalition for Epidemic Preparedness Innovations' (CEPI's ...

Examine, a free weekly newsletter covering science with a sceptical, evidence-based eye, is sent every Tuesday. You’re ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

Africa bears a disproportionate infectious disease burden, with HIV, tuberculosis, and malaria posing ongoing threats ...

Revenue-generating with an exciting, diversified, largely externally funded, advanced development pipeline and multiple upcoming catalysts. Recent highlights: Global ...

Vaccination protected from viremia, weight loss and death following challenge with a lethal Marburg virus dose. Evaluation of immune responses following vaccination demonstrated the presence of both ...